Last reviewed · How we verify

NCT07351331: EPIEMG

Intratissue Electrolysis (EPI) is Effective in Deactivating Myofascial Trigger Points (MTrPs). (EPIEMG)

Completed NA Last updated 20 January 2026
What this trial tests

NA trial testing Intratissue Percutaneous Electroly in Myofascial Pain Syndrome (MPS) in 40 participants. Completed in 24 April 2025.

Timeline
15 November 2024
Primary endpoint
28 February 2025
24 April 2025

Quick facts

Lead sponsorCamilo Jose Cela University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date15 November 2024
Primary completion28 February 2025
Estimated completion24 April 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Camilo Jose Cela University

Who can join

Adults 18 to 65, any sex, with Myofascial Pain Syndrome (MPS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Invasive physiotherapy techniques, such as Intratissue Percutaneous Electroly-sis (IPE), have numerous beneficial effects depending on the pathology being treated, in-cluding the deactivation of myofascial trigger points (MTP) caused by myofascial pain syndrome (MPS). The objectives are (1) evaluate the effectiveness of low intesity IPE treatment com-pared to DN on the shortening of FHB in patients with MPS, in 4 and 12 weeks evaluation, (2) assess the distribution of plantar pressures after the interventions and (3) evaluate the modification of FHB activation following the interventions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myofascial Pain Syndrome (MPS)

Currently open trials in the same condition.

Other Camilo Jose Cela University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07351331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing